Literature DB >> 27186865

Quantifying the changes in survival inequality for Indigenous people diagnosed with cancer in Queensland, Australia.

Peter D Baade1, Paramita Dasgupta2, Paul W Dickman3, Susanna Cramb2, John D Williamson4, John R Condon5, Gail Garvey5.   

Abstract

The survival inequality faced by Indigenous Australians after a cancer diagnosis is well documented; what is less understood is whether this inequality has changed over time and what this means in terms of the impact a cancer diagnosis has on Indigenous people. Survival information for all patients identified as either Indigenous (n=3168) or non-Indigenous (n=211,615) and diagnosed in Queensland between 1997 and 2012 were obtained from the Queensland Cancer Registry, with mortality followed up to 31st December, 2013. Flexible parametric survival models were used to quantify changes in the cause-specific survival inequalities and the number of lives that might be saved if these inequalities were removed. Among Indigenous cancer patients, the 5-year cause-specific survival (adjusted by age, sex and broad cancer type) increased from 52.9% in 1997-2006 to 58.6% in 2007-2012, while it improved from 61.0% to 64.9% among non-Indigenous patients. This meant that the adjusted 5-year comparative survival ratio (Indigenous: non-Indigenous) increased from 0.87 [0.83-0.88] to 0.89 [0.87-0.93], with similar improvements in the 1-year comparative survival. Using a simulated cohort corresponding to the number and age-distribution of Indigenous people diagnosed with cancer in Queensland each year (n=300), based on the 1997-2006 cohort mortality rates, 35 of the 170 deaths due to cancer (21%) expected within five years of diagnosis were due to the Indigenous: non-Indigenous survival inequality. This percentage was similar when applying 2007-2012 cohort mortality rates (19%; 27 out of 140 deaths). Indigenous people diagnosed with cancer still face a poorer survival outlook than their non-Indigenous counterparts, particularly in the first year after diagnosis. The improving survival outcomes among both Indigenous and non-Indigenous cancer patients, and the decreasing absolute impact of the Indigenous survival disadvantage, should provide increased motivation to continue and enhance current strategies to further reduce the impact of the survival inequalities faced by Indigenous people diagnosed with cancer.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Indigenous; Inequalities; Mortality; Survival

Mesh:

Year:  2016        PMID: 27186865     DOI: 10.1016/j.canep.2016.05.002

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  5 in total

1.  Cancer survival differentials for Aboriginal and Torres Strait Islander peoples in Queensland: the impact of remoteness.

Authors:  S M Cramb; L J Whop; G Garvey; P D Baade
Journal:  Cancer Causes Control       Date:  2022-10-20       Impact factor: 2.532

2.  Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.

Authors:  Vincent Y F He; John R Condon; Peter D Baade; Xiaohua Zhang; Yuejen Zhao
Journal:  Popul Health Metr       Date:  2017-01-17

3.  Emerging cancer incidence, mortality, hospitalisation and associated burden among Australian cancer patients, 1982 - 2014: an incidence-based approach in terms of trends, determinants and inequality.

Authors:  Rashidul Alam Mahumud; Khorshed Alam; Jeff Dunn; Jeff Gow
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

4.  Quantifying the number of deaths among Aboriginal and Torres Strait Islander cancer patients that could be avoided by removing survival inequalities, Australia 2005-2016.

Authors:  Paramita Dasgupta; Gail Garvey; Peter D Baade
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

5.  Factors associated with cancer survival disparities among Aboriginal and Torres Strait Islander peoples compared with other Australians: A systematic review.

Authors:  Paramita Dasgupta; Veronica Martinez Harris; Gail Garvey; Joanne F Aitken; Peter D Baade
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.